CAS No.: 105816-04-4
Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes. Nateglinide was developed by the Swiss pharmaceutical company Novartis.
Nateglinide belongs to the meglitinide class of blood glucose-lowering drugs.
For more information of product, please send the email to firstname.lastname@example.org
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.This form is unable to receive your inquiry from aol, hotmail, gmail or others but company email address.
TEL: +86 592 536 5868
WHATSAPP: +86 189 6516 2351